Cambridge, MA
StataDX is building the world's first point-of-care diagnostics platform for Neurology.
statadx.comThese are collections StataDx is a part of. Click on the collection name to view similar companies.
Series A
$500,000
Seed
$2,700,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on StataDx.